drugset / Trial / NCT03426553
Clinical Use of Pathogen Reduced Red Blood Cell Suspension
Phase 3
Completed
50 enrolled
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Non-randomizedParallel-groupTriple-blindSupportive care
Summary
The aim of the study is to evaluate the effectiveness and safety of the application of pathogen inactivated RBC suspension in children with oncological and hematological diseases.
Timeline
- Start
- 2018-01-15
- Primary completion
- 2018-09-17
- Completion
- 2018-12-17
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Riboflavin | Other / unclassified | — | Other |
| Comparator | irradiated RBC | Unknown | — | Other |